Lv2
130 积分 2022-09-15 加入
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
7天前
已完结
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
7天前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
26天前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
26天前
已完结
Predictors of poor prognosis in Guillain-Barre’ syndrome: a study of 22 years from a single Italian Center
29天前
已完结
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome
1个月前
已完结
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
1个月前
已完结
Guillain-Barré syndrome
1个月前
已完结
Association of Albumin Levels With Outcome in Intravenous Immunoglobulin–Treated Guillain-Barré Syndrome
1个月前
已完结
Current treatment practice of Guillain-Barré syndrome
1个月前
已完结
皖公网安备34019202002308
